Renal Denervation Systems Market PPT 2022: Size, Growth, Demand and Forecast till 2027

1
Global Renal Denervation Systems Market Research
and Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Renal Denervation Systems Market Research
Report 2022-2027 According to the latest report
by IMARC Group, titled "Renal Denervation Systems
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast
2022-2027," the global renal denervation systems
market size reached US 218.2 Million in 2021.
Renal denervation (RDN) refers to a minimally
invasive, catheter-based procedure that is
performed to treat resistant hypertension. It
involves a radiofrequency ablation, which burns
the nerves within the renal arteries. This, in
turn, suppresses the nerve activity and modulates
the output of the sympathetic nerves, thereby
assisting in decreasing the blood pressure. In
addition to this, it lowers renin secretion,
improves blood flow, and stimulates natriuresis.
Consequently, RDN systems is being widely adopted
to treat hypertension coexisting with metabolic
abnormalities, sleep apnea, heart failure,
chronic kidney disease, and arrhythmias. Request
for a PDF sample of this report
https//www.imarcgroup.com/renal-denervation-syste
ms-market/requestsample

4
Report Description and Highlights
Report Description
Global Renal Denervation Systems Market
Trends The global RDN systems market is majorly
being driven by the growing instances of
lifestyle-related disorders, such as
therapy-resistant hypertension, due to sedentary
lifestyle, evolving dietary habits, and the
increasing cigarette smoking population. This is
further supported by the rising geriatric
population, which is more susceptible to
developing such ailments. Moreover, the
growingawareness regarding the clinical
advantages associated with RDN systems, including
quick recovery, cost-effectiveness, and minimal
complications are also facilitating the product
demand across the globe. Other than this,
continuous investments in research and
development (RD) activities to introduce
alternative technologies for RDN, such as
micro-infusion, is acting as another
growth-inducing factor. Additionally, increasing
clinical trials to validate clinical efficiency
of RDN over conventional surgeries are creating a
positive outlook for the market further. Looking
forward, the market is expected to grow at a CAGR
of 40.67 during 2022-2027. View Report TOC,
Figures and Tables https//www.imarcgroup.com/ren
al-denervation-systems-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product Type
• Catheters
• Single Electrode Catheter
• Multi Electrode Catheter
• RF Generator
• Nerve Modifying Agents
• Breakup by Product
• Symplicity
• Vessix (V2)
• EnligHTN
• Paradise
• Iberis
• Others
• Breakup by Technology
• Ultrasound Ablation

6
Report Description and Highlights
Report Description

• Radiofrequency Ablation
• Microinfusion
• Breakup by Application
• Hypertension
• Cardiac Disorders
• Diabetes
• Renal Failure
• Others
• Breakup by End User
• Diagnostic Centers and Hospitals
• Ambulatory Care Centers
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Boston Scientific Group
• Kona Medical Inc
• Medtronic Plc
• Mercator MedSystems
• ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
• Renal Dynamics
• St. Jude Medical Inc. (Abbott)
• Terumo Corporation
•  

8
Key Questions Answered in the Report
Report Description

• How has the global renal denervation systems
  market performed so far and how will it perform
  in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the
  global renal denervation systems market?
• What is the breakup of the market based on the
  product type?
• What is the breakup of the market based on the
  product?
• What is the breakup of the market based on the
  technology?
• What is the breakup of the market based on the
  application?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global renal
  denervation systems market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Renal Denervation
Systems Market    5.1    Market Overview    5.2
   Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Product Type    6.1  
 Catheters        6.1.1 Market Trends       
6.1.2 Major Types 6.1.2.1 Single
Electrode Catheter 6.1.2.2 Multi
Electrode Catheter 6.1.3 Market
Forecast    6.2    RF Generator        6.2.1
Market Trends        6.2.2 Market Forecast   
6.3    Nerve Modifying Agents        6.3.1
Market Trends        6.3.2 Market Forecast7  
 Market Breakup by Product    7.1  
 Symplicity        7.1.1 Market Trends       
7.1.2 Market Forecast          Click here to
visit the complete table of content with list of
figures and tables https//www.imarcgroup.com/ren
al-denervation-systems-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us